BMS 189453

Known as: BMS-189453 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
01220012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AIM To establish a mouse model for the study of congenital defects, using exposure of pregnant females to the teratogen BMS… (More)
Is this relevant?
Review
2013
Review
2013
A non-hormonal male contraceptive is a contraceptive that does not involve the administration of hormones or hormone blockers… (More)
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Although myocyte cell transplantation studies have suggested a promising therapeutic potential for myocardial infarction, a major… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?
2011
2011
Here we investigated a pharmacological approach to inhibit spermatogenesis in the mouse model by manipulating retinoid signaling… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
BACKGROUND A proposed mechanism for ethanol teratogenicity entails ethanol-mediated reductions in retinoic acid (RA). This… (More)
Is this relevant?
2006
2006
BACKGROUND The morphogenetic mechanisms that are responsible for the transposition of the great arteries are still largely… (More)
Is this relevant?
2003
2003
The foot processes forming the slit diaphragm are disrupted in diseases associated with proteinuria. Although they are often… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
OBJECTIVE To investigate the usefulness of a novel retinoic acid receptor (RAR) antagonist (BMS-189453) in animal models of… (More)
Is this relevant?
2001
2001
BMS-189453 is a synthetic retinoid that acts as an antagonist at retinoic acid receptors alpha, beta, and gamma. In Sprague… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?